Title |
Mesenchymal and induced pluripotent stem cells: general insights and clinical perspectives
|
---|---|
Published in |
Stem cells and cloning advances and applications, September 2015
|
DOI | 10.2147/sccaa.s88036 |
Pubmed ID | |
Authors |
Helena D Zomer, Atanásio S Vidane, Natalia N Gonçalves, Carlos E Ambrósio |
Abstract |
Mesenchymal stem cells have awakened a great deal of interest in regenerative medicine due to their plasticity, and immunomodulatory and anti-inflammatory properties. They are high-yield and can be acquired through noninvasive methods from adult tissues. Moreover, they are nontumorigenic and are the most widely studied. On the other hand, induced pluripotent stem (iPS) cells can be derived directly from adult cells through gene reprogramming. The new iPS technology avoids the embryo destruction or manipulation to generate pluripotent cells, therefore, are exempt from ethical implication surrounding embryonic stem cell use. The pre-differentiation of iPS cells ensures the safety of future approaches. Both mesenchymal stem cells and iPS cells can be used for autologous cell transplantations without the risk of immune rejection and represent a great opportunity for future alternative therapies. In this review we discussed the therapeutic perspectives using mesenchymal and iPS cells. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 282 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 49 | 17% |
Student > Master | 44 | 16% |
Student > Ph. D. Student | 41 | 15% |
Researcher | 30 | 11% |
Student > Doctoral Student | 15 | 5% |
Other | 24 | 9% |
Unknown | 79 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 63 | 22% |
Agricultural and Biological Sciences | 36 | 13% |
Medicine and Dentistry | 34 | 12% |
Engineering | 21 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 9 | 3% |
Other | 30 | 11% |
Unknown | 89 | 32% |